| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.008 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |